Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Action modulators |
Mechanism Trop-2 modulators(Tumor-associated calcium signal transducer 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Non-Small Cell Lung Cancer | Preclinical | United States | 01 Dec 2024 | |
| Triple Negative Breast Cancer | Preclinical | United States | 01 Dec 2024 |






